Compound Detail
CHEMBL4464871
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)CCCOc4cc5c(cc4OC)C(=O)N4c6ccccc6C[C@H]4C=N5)cn3C)ccc2s1
Basic Information
| ChEMBL ID | CHEMBL4464871 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FOSYTQJQYPAZSU-VWLOTQADSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
691.8
MW (Da)
6.37
ALogP
10
HBA
2
HBD
140.6
PSA (Ų)
0.13
QED
2
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 11.0
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| KB | IC50 | = | 0.01 | nM | 11.0 | Cytotoxicity against human KB cells assessed as reduction in cell viability afte... | 31350125 |
| NAMALVA | IC50 | = | 0.02 | nM | 10.7 | Cytotoxicity against human NAMALWA cells assessed as reduction in cell viability... | 31350125 |
| Unchecked | IC50 | = | 0.05 | nM | 10.3 | Cytotoxicity against human NCI-H2110 cells assessed as reduction in cell viabili... | 31350125 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31350125 | 10.1016/j.bmcl.2019.07.031 | KB | 1 |
| 31350125 | 10.1016/j.bmcl.2019.07.031 | Unchecked | 1 |
| 31350125 | 10.1016/j.bmcl.2019.07.031 | NAMALVA | 1 |
Data from ChEMBL 36 via Core Engine